REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilink Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Unilink Pharma Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Unilink Pharma Private Limited is an unlisted company, incorporated on 23/02/2005. It has its registered office in the State of Tamil Nadu, India. Company's corporate identification number (CIN) is U24232TN2005PTC055459 and registration number is 055459. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
New No.111, Old No.23Parthasarathypuram T Nagar
Chennai; Tamil Nadu; Postal Code: 600017

Contact Details: Purchase the Unilink Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Unilink Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Unilink Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Unilink Pharma Private Limited report to view the information.
Incorporation Date:
February 23, 2005
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Unilink Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
14.96%
Total operating revenue
13.87%
Operating profit (EBIT)
-25.58%
EBITDA
-19.08%
Net Profit (Loss) for the Period
-4.66%
Total assets
18.84%
Total equity
12.29%
Operating Profit Margin (ROS)
-3.09%
Net Profit Margin
-1.02%
Return on Equity (ROE)
-2.08%
Debt to Equity Ratio
4.65%
Quick Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?